Navigation Links
Maxygen in Medical News

Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts

...lseres Pharmaceuticals Inc, Ceregene Inc, FibroGen Inc, FzioMed Inc, GeneMedix Plc, Insmed Inc, Johnson & Johnson, Janssen-Ortho Inc, Lonza Group, maxygen Inc, Merck Serono International SA, NsGene A/S, PeproTech Inc, Rentschler Biotechnologie GmbH, F Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co Ltd, ...

Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008

...e passcode 60709469. An archived version of the webcast will be available until March 12, 2008 at http://www.maxygen.com/webcasts . About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. We look for opportunities where our proprietary protein modif...
Maxygen in Medical Technology

Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF

...an result in cancer progression. About Maxygen maxygen is a biopharmaceutical company focused on developi...iodic SEC reports, all of which are available from maxygen at http://www.maxygen.com . maxygen disclaims any obligation to update or revise any f...

Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered ''Cured''

...ompounds currently in human development that target the virus in a number of different ways. The development of R1626 and partnerships with InterMune, maxygen and Pharmasset, all underscore our long-term commitment to finding effective new therapies with the goal of successfully treating more patients with c...
Maxygen in Biological Technology

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...London Main Market, U.K.: BGC) COUGAR BIOTECHNOLOGY INC (NASDAQ: CGRB ) EXELIXIS INC (NASDAQ: EXEL ) LIGAND PHARMACEUTICALS INC (NASDAQ: LGND ) maxygen INC (NASDAQ: MAXY ) MOLECULAR INSIGHT PHARM INC (NASDAQ: MIPI ) MORPHOSYS (Frankfurt, Germany: MOR) NEKTAR THERAPEUTICS (NASDAQ: NKTR ) PROTHER...

Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program

... productivity and progress towards a viable HIV vaccine." About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of p... new CTLA4-Ig product candidates for the treatment of rheumatoid arthritis. maxygen uses its proprietary DNA shuffling technology and extensive protein modific...

Maxygen to Present at the Cowen & Company 28th Annual Health Care Conference

...replay of the presentation will be available for 90 days. About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of p... new CTLA4-Ig product candidates for the treatment of rheumatoid arthritis. maxygen uses its proprietary DNA shuffling technology and extensive protein modific...

Maxygen Announces Management Changes

.... Rabson's responsibilities. Mr. Yonehiro joined maxygen in May 2003 as vice president of business developm...rting directly to the CEO. Dr. Kruse has been with maxygen since March 1998. John Borkholder, who joined maxygen in November 2005 as senior corporate counsel, has ...

Maxygen Reports Fourth Quarter and Year End 2007 Financial Results

... Quarter Results For the fourth quarter of 2007, maxygen reported a net loss of $11.3 million, or $0.31 per...nmark facility closure. Full Year 2007 Results maxygen reported a net loss of $49.3 million, or $1.34 per...prior year. Excluding the impact of SFAS 123(R), maxygen reported a non-GAAP net loss of approximately $42....

Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference

... the presentation will be available until March 19, 2008. About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of p... new CTLA4-Ig product candidates for the treatment of rheumatoid arthritis. maxygen uses its proprietary DNA shuffling technology and extensive protein modific...

Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference

...n be accessed on Maxygen's website at http://www.maxygen.com/webcasts . A replay of the presentation will be available for 90 days. About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. We look for opportunities where our proprietary protein modif...

Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference

...ed on Maxygen's website at http://www.maxygen.com/webcasts . A replay of the presentation will be available until February 7, 2008. About Maxygen maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. We look for opportunities where our proprietary protein modif...

Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur

...aventis Group. Under the terms of the agreement, maxygen will transfer to sanofi pasteur a portfolio of pre...gue Hemorrhagic Fever. To overcome this challenge, maxygen used its proprietary MolecularBreeding(TM) directe...Medicine, Inc., and the US Navy. About Maxygen maxygen is a biopharmaceutical company focused on developi...

Maxygen Reports Third Quarter 2007 Financial Results

... results for the quarter ended September 30, 2007. maxygen reported a net loss of $14.7 million, or $0.40 per...sh stock compensation expense under SFAS 123( R ), maxygen reported a non-GAAP net loss (see Footnote A) of a.... MAXY-VII is a next-generation Factor VIIa, which maxygen is currently developing for the treatment of hemop...
Other Tags
(Date:12/21/2014)... Mi (PRWEB) December 21, 2014 AlignLife ... child in need while at the same time helping people ... is a non-profit community-based organization committed to serving those persons ... meet their needs to improve the quality of life. Dr. ... make an impact in the local community and he knew ...
(Date:12/21/2014)... 21, 2014 Parker & Sons, Inc. ... cooling, plumbing and other similar home contractor services announces ... regard to its expert contracting services. The company is ... has been serving Arizona for well over 40 years. ... absolute best in quality customer service to the residents ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 SCI ... of the issues and systemic barriers for disabled athletes ... Paratriathlon Champion. Scheidies has a condition called juvenile macular ... He describes how he adapted his athletic ambitions to ... his success in triathlon to pioneer the way for ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 As ... alleging heart attacks, stroke and blood clots from using ... increase, a new study shows that the male hormone ... cancer. In a study published in the Proceedings of ... James Amos-Landgraf examined a group of male rats with ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation hosted ... Whittier offices. The Hope for the Holidays Toy Drive is ... their families during the holiday season. This year, the toy ... between both offices. This event continues to be successful year ... team, store managers and assistant managers came out and not ...
Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
Other Contents